FATE THERAPEUTICS INC
Develops off-the-shelf iPSC cell therapies for cancer and autoimmune diseases.
FATE | NDAQ
Overview
Corporate Details
- ISIN(s):
- US31189P1021
- LEI:
- Country:
- United States of America
- Address:
- 12278 SCRIPPS SUMMIT DRIVE, 92131 SAN DIEGO
- Website:
- https://fatetherapeutics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing first-in-class cellular immunotherapies for cancer and autoimmune diseases. The company utilizes its proprietary induced pluripotent stem cell (iPSC) platform to advance a pipeline of universal, "off-the-shelf" cell product candidates. These multiplexed-engineered therapies are designed to overcome key manufacturing and commercial limitations of conventional cell therapies. By incorporating novel synthetic controls of cell function, Fate's product candidates are intended to deliver multiple therapeutic mechanisms, aiming to make life-changing cell therapies routine and accessible for patients with life-threatening diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all FATE THERAPEUTICS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for FATE THERAPEUTICS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for FATE THERAPEUTICS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
